PSYCHOPHARMACOLOGY
200+ EXAM Q&AS BANK
(WITH RATIONALES) – FULL
LATEST VERSION
Advanced Advanced Pathophysiology & Pharmacology (NURS
5462) Practice Examination
Question 1
A 58-year-old male with a history of chronic kidney disease (CKD) Stage
4 presents to the clinic reporting severe fatigue and shortness of breath
with minimal exertion. His laboratory results reveal a hemoglobin level
of 8.2 g/dL, a hematocrit of 25%, and normal iron stores. The nurse
practitioner understands that the primary pathophysiological
mechanism responsible for this patient’s anemia is a deficiency in which
of the following substances?
A. Intrinsic factor
B. Thrombopoietin
C. Erythropoietin
D. Granulocyte colony-stimulating factor
Rationale: Erythropoietin (EPO) is a glycoprotein hormone produced
primarily by the interstitial fibroblasts in the peritubular capillary
network of the renal cortex. In Stage 4 CKD, structural damage to the
renal parenchyma severely impairs the kidneys' ability to synthesize
sufficient EPO in response to tissue hypoxia. Without adequate EPO, the
bone marrow lacks the necessary signaling to stimulate the
proliferation and differentiation of proerythroblasts, leading to
normocytic, normochromic anemia. Intrinsic factor is produced by
gastric parietal cells, thrombopoietin by the liver, and G-CSF regulates
white blood cell production.
Question 2
,A 64-year-old female is prescribed lisinopril for the management of
hypertension and early-stage heart failure. Three weeks after initiating
therapy, she develops a persistent, dry, non-productive cough that
interferes with her sleep. The clinician plans to transition the patient to
an angiotensin II receptor blocker (ARB) like losartan. Which of the
following statements best explains the biochemical mechanism
underlying the development of this drug-induced cough?
A. Increased systemic conversion of angiotensin I to angiotensin II via
alternative pathways.
B. Accumulation of bradykinin and substance P in the
respiratory tract due to enzyme inhibition.
C. Direct activation of pulmonary beta-2 adrenergic receptors causing
bronchoconstriction.
D. Downregulation of AT1 receptors leading to localized alveolar
inflammation.
Rationale: Angiotensin-converting enzyme (ACE) is identical to
kininase II, an enzyme responsible for degrading kinins, specifically
bradykinin and substance P. When an ACE inhibitor like lisinopril is
administered, it blocks this degradation process, leading to an
accumulation of bradykinin and substance P in the upper respiratory
tract. These inflammatory peptides sensitize peripheral sensory
afferent C-fibers in the airway, triggering the dry cough reflex. ARBs
do not inhibit ACE/kininase II and therefore do not increase bradykinin
levels, making them a suitable alternative.
Question 3
A 45-year-old female presents with clinical manifestations of primary
hyperparathyroidism, including recurrent nephrolithiasis, diffuse bone
pain, and muscle weakness. Laboratory evaluation confirms marked
hypercalcemia and elevated serum parathyroid hormone (PTH) levels.
Which of the following cellular responses directly mediates the bone
resorption observed in this patient’s condition?
A. Direct PTH stimulation of osteoclasts via targeted G-protein coupled
surface receptors.
B. Osteoblast secretion of RANK ligand (RANKL) which binds
to RANK receptors on osteoclast precursors.
C. Increased osteocyte production of osteoprotegerin (OPG) causing
accelerated bone remodeling.
D. Inhibition of the calcium-sensing receptor (CaSR) within the
extracellular bone matrix.
,Rationale: Osteoclasts do not possess functional receptors for PTH.
Instead, PTH binds directly to its receptors on osteoblasts. This binding
induces the osteoblasts to upregulate and express Receptor Activator of
Nuclear Factor KB Ligand (RANKL) and downregulate osteoprotegerin
(OPG), a decoy receptor. RANKL on the osteoblast surface or in
secreted form then binds to RANK receptors on osteoclast precursors
and mature osteoclasts, promoting their differentiation, survival, and
activation, which accelerates bone resorption and drives serum calcium
upward.
Question 4
A 72-year-old patient with a long history of poorly controlled type 2
diabetes mellitus presents with burning pain, numbness, and
paresthesias in both feet in a "stocking" distribution. The underlying
pathophysiology involves metabolic alterations that damage peripheral
nerves. Which of the following pathways describes how intracellular
hyperglycemia directly contributes to this diabetic peripheral
neuropathy?
A. Underproduction of advanced glycation end-products (AGEs) leading
to myelin sheath thinning.
B. Excessive activation of protein kinase C (PKC) resulting in local
microvascular vasodilation.
C. Shunting of excess glucose into the polyol pathway, causing
sorbitol accumulation and oxidative stress.
D. Upregulation of the hexosamine pathway which enhances
neurotrophic factor synthesis.
Rationale: In states of sustained intracellular hyperglycemia, the
enzyme aldose reductase shunts excess intracellular glucose into the
polyol pathway, converting glucose into sorbitol, which is then slowly
converted to fructose by sorbitol dehydrogenase. Sorbitol cannot easily
cross cell membranes and accumulates intracellularly, creating an
osmotic gradient that causes cellular swelling. Furthermore, this
pathway consumes NADPH, depleting the cell's reserves of reduced
glutathione, which directly exacerbates oxidative stress, damages
Schwann cells, and compromises axonal function.
Question 5
A 29-year-old female in her third trimester of pregnancy develops severe
right lower quadrant abdominal pain, fever, and leukocytosis. She is
diagnosed with acute appendicitis and undergoes an emergency
, appendectomy. Histopathological examination of the excised appendix
reveals a dense transmural infiltration of polymorphonuclear
neutrophils. Which of the following chemical mediators is primarily
responsible for recruiting these specific leukocytes to the site of acute
inflammation?
A. Interleukin-10 (IL-10)
B. Transforming growth factor-beta (TGF-β)
C. Leukotriene B4 (LTB4) and Interleukin-8 (IL-8)
D. Prostaglandin E2 (PGE2)
Rationale: Leukotriene B4 (LTB4) and Interleukin-8 (IL-8) are potent
chemotactic agents for neutrophils. During acute inflammation,
resident macrophages and damaged endothelial cells release IL-8,
while the lipoxygenase pathway converts arachidonic acid into LTB4.
These substances create a chemical gradient that guides neutrophils
through the vascular wall (diapedesis) toward the site of tissue injury.
IL-10 and TGF-β are anti-inflammatory cytokines, while PGE2
primarily mediates vasodilation, increased vascular permeability, and
pain sensitization.
Question 6
A 68-year-old male with a history of severe chronic obstructive
pulmonary disease (COPD) is admitted with an acute exacerbation
characterized by increased sputum purulence and worsening dyspnea.
Arterial blood gas (ABG) analysis on room air reveals a pH of 7.32,
PaCO2 of 58 mmHg, and PaO2 of 52 mmHg. Which of the following
physiological compensatory mechanisms is initiated by the central
chemoreceptors in response to this patient’s acid-base imbalance?
A. Decreased firing rate to the medullary respiratory center to minimize
further air trapping.
B. Stimulation of the respiratory center to increase
ventilation, driven by hydrogen ion accumulation in the
cerebrospinal fluid.
C. Rapid renal conservation of bicarbonate ions within minutes of the
arterial PaCO2 elevation.
D. Peripheral chemoreceptor inhibition to prevent excessive sympathetic
nervous system activation.
Rationale: Central chemoreceptors, located near the ventrolateral
surface of the medulla oblongata, are highly sensitive to changes in the
hydrogen ion concentration (\(H^{+}\)) of the brain extracellular fluid